Importance & Scope:
Dementia is a general term that describes a group of symptoms-such as loss of memory, judgment, language, complex motor skills, and other intellectual function-caused by the permanent damage or death of the brain's nerve cells, or neurons.
Dementia, including Alzheimer’s disease, is one of the biggest global public health challenges facing our generation.
Globally, results of a recent meta-analysis suggest that 35.6 million people lived with dementia worldwide in 2010, with numbers expected to almost double every 20 years, to 65.7 million in 2030 and 115.4 million in 2050. In 2010, 58 percent of all people with dementia lived in countries with low or middle incomes, with this proportion anticipated to rise to 63 percent in 2030 and 71 percent in 2050.This number is expected to double by 2030 and more than triple by 2050 to 115 million.
In the United States alone, experts estimate that as many as five million people age 65 and older suffer from Alzheimer’s disease.
Why inToronto, Canada?
According to the Canada government, an estimated 747,000 Canadians were living with Alzheimer's disease or other forms of dementia in 2011.
In Canada 72% of Alzheimer's sufferers are women and 62% of dementia cases are also women. Much of the increase will be in developing countries like Western Europe and North America. Already 62% of people with dementia live in developing countries.
Nearly 800,000 Canadians are currently living with Alzheimer’s disease or other forms of dementia. By 2031, that number will likely double.
In two decades, it is estimated that 1.4 million Canadians will have dementia, costing the economy almost $300 billion per year.
People with Dementia in Toronto
Figure 1: Statistical Analysis of People with Dementia in Toronto
People with Dementia in Canada
Figure 2: Statistical Analysis of People with Dementia in Canada
Toronto is Canada's largest city, the fourth largest in North America, and home to a diverse population of about 2.8 million people. It's a global center for business, finance, arts and culture and is consistently ranked one of the world's most livable cities. The Greater Toronto Area (GTA) is a modern multicultural urban center with something for everyone. Year round, the GTA offers a unique mix of historical attractions, seasonal celebrations, family fun and a safe, walkable downtown core.
Conference Highlights:
- Fast Facts: Dementia
- Dementia Causes, Concerns and Preventions
- Managing Dementia
- Dementia Medication
- Clinical Trials & Case Study
- New Drug Discovery: Animal Models and Translational Research
- Managing Dementia
- Dementia Medication
- Clinical Trials & Case Study
- Clinical Trials & Case Study
Why to attend???
Dementia-2015 will provide an opportunity for all stakeholders working on Alzheimer’s disease and Dementia to talk about their work. Dementia- 2015 will congregate renowned speakers, principal investigators, experts, neurologist’s and Dementia researchers from both academia and health care industry will join together to discuss their views and research. The conference will be comprised of sessions by world class experts in the field of neurology. In Euro Psychiatry Summit-2015, international symposiums, B2B meetings, international workshops will also be organized to discuss the specific topics in the field of Dementia and Neurology.
A Unique Opportunity for Advertisers and Sponsors at this International event:
http://omicsgroup.com/conferences/ACS/conference/pdfs/dementia2015_Sponsorship.pdf
Members Associated with Dementia
Canadian Consortium on Neurodegeneration in Aging (CCNA) it brings together 340 researchers from across the country.
Their research will focus on improving the quality of life of those already living with Alzheimer’s disease and other forms of dementia.
The consortium is supported with funding of $31.5 million over five years from the Government of Canada through the Canadian Institutes of Health Research and a group of 13 partners from the public and private sectors, including the Alzheimer Society of Canada and Fonds de recherche du Québec – Santé. Jewish General Hospital (Montreal)
- University of Ottawa
- Mount Sinai Hospital-TORONTO
- University of Alberta
- McGill University
- The Canadian Institutes of Health Research
- Canadian Consortium on Neurodegeneration in Aging (CCNA)
Hospitals Associated with Dementia
About 200 Organizations Providing Dementia Services in Toronto
- Mount Sinai
- A.G.E. Matters Clinic
- Ability Heath Care Supplies
- Comforcare Toronto Central
- Craig lee Nursing Home
- Distress Centers of Toronto
- Eatonville Care Centre
- Eldercare Home Health Inc.
- Fairview Nursing Home
Alzheimer Association & Societies around the Globe
- Alzheimer's Australia
- Albanian Alzheimer Society
- Asociación de Lucha contra el Mal de Alzheimer
- Asociación de Lucha contra el Mal de Alzheimer
- Fundacion Alzheimer Aruba (FAA)
- Alzheimer's Australia
- Alzheimer Austria
- Alzheimer Support Group
- Alzheimer Society of Bangladesh
- Barbados Alzheimer's Association Inc.
- Alzheimer’s and Dementia Association of The Cayman Islands
- Ligue National Alzheimer Liga
- Alzheimer's Family Support Group
- Asociación Boliviana de Alzheimer y Otras Demencias
- FEBRAZ - Federação Brasileira de Associaçãoes de Alzheimer
- Corporation Alzheimer Chile
- Alzheimer's disease Chinese
Alzheimer Association & Societies in Canada
- Alzheimer Society of Ontario
- Alzheimer's disease International
- Dementia Networks across Ontario
- Alzheimer's Education and Referral Center
- Alzheimer Research Forum
- Alzheimer Knowledge Exchange
- Murray Alzheimer Research and Education Program (MAREP) University of Waterloo
Universities in Canada:
- University of Toronto
- University of British Columbia
- University of Alberta
- Simon Fraser University
- University of Waterloo
- McGill University
- University of Calgary
- Queen’s University
- York University
- University of Victoria
Universities associated with dementia in globally
Figure 4:Universities associated with dementia
Target Audience:
Neurologists and Directors, Physicians, Neuroscientists, Specialists, researchers, health care professionals, Professors, Lecturers and Students from Academia in the study of Dementia
Market Value and Growth on Dementia:
- Economic cost of dementia in Canada 2011 $33 billion
- Globally, dementia cost $600 billion in a year
- In two decades, it is estimated that 1.4 million Canadians will have dementia, costing the economy almost $300 billion per year
- From 2003-2013 CIHR funding for dementia research was $236 million
- The Pfizer drug dominates sales, with about $ 4 billion annually
Aricept (Donepezil-generic) (Pfizer)
- Ranbaxy market size of Aricept (Donepezil Hydrochloride) in Canada is $ 153.9 million
- Razadyne (Johnson & Johnson) market size is $ 5.3 billion
- Exelon (Novartis)
- Namenda (Forest Laboratories) spending for dementia research was $236 million
Products manufactured by the industries
Three drugs are available in Canada to treat symptoms in people with Mild to moderate Alzheimer’s disease
Aricept™ produced by Pfizer Canada Inc.,
Exelon™ produced by Novartis Pharma Canada Inc.
Reminyl™ produced by Janssen Ortho Inc.
Two drugs for Moderate to advanced Alzheimer’s disease
Ebixa®
Aricept™
Alzheimer’s disease and Dementia in numbers...
Fund Allotment to Dementia
National dementia research initiative gets $31.5M funding from the federal government and several partners, as well as an additional, separate $24 million from partners in Ontario and Quebec. In two decades, it is estimated that 1.4 million Canadians will have dementia, costing the economy almost $300 billion per year.
References:
- http://www.cihr-irsc.gc.ca/e/45554.html
- http://www.providencecare.ca/clinical-tools/Documents/Ontario-Dementia-Projections-2010.pdf
- http://www.concordia.ca/cunews/main/stories/2014/09/16/revolutionizing-alzheimersresearchincanada.htm
- http://www.dementiatoronto.org/allagencies.asp
- http://www.cbc.ca/news/health/national-dementia-research-intitiative-gets-31-5m-federal-funding-1.2762253
- http://seekingalpha.com/article/2042953-following-the-latest-in-alzheimers-research-as-an-investor
- http://www.alzheimer.ca/en/Living-with-dementia/Treatment-options/Drugs-approved-for-Alzheimers-disease
- http://news.gc.ca/web/article-en.do;jsessionid=a0a6a2037001e091ddee53f66c5dc11c8e26df830028d1e9d682dde6c1b6ecd8.e38RbhaLb3qNe38Kbxj0?mthd=tp&crtr.page=3&nid=883019&crtr.tp1D=1
- http://www.jghfoundation.org/sections/vpadd.html
|
